QGA
DRTSW icon

Q Global Advisors’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Q Global Advisors’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-299,900
Closed -$183K – 270
2022
Q1 		$183K Buy
+299,900
New +$164K 0.11% 17

Other funds holding DRTSW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return

Q Global Advisors's DRTSW Position: Q2 2022 in Review

Q Global Advisors sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2022, closing a stake of 299,900 shares — an estimated $183K sold.

Q Global Advisors first reported a position in DRTSW in Q1 2022 and held it in 1 quarter. The position peaked at $183K in Q1 2022. 37 funds tracked by Wall St. Rank hold DRTSW as of Q2 2022.

  • Q Global Advisors reported no remaining Alpha Tau Medical Warrant position as of Q2 2022 after selling out during the quarter.
  • Q Global Advisors sold 299,900 Alpha Tau Medical Warrant shares in Q2 2022, an estimated $183K.
  • Q Global Advisors first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 1 quarter.
  • Q Global Advisors's Alpha Tau Medical Warrant position peaked at $183K in Q1 2022.
  • 37 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2022.

Based on Q Global Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.